Company / Net Income
Collegium Pharmaceutical, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$62.9M
FY2025
5-year range
-$25.0M / $71.5M
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
#47 of 216
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s net income of $63M is higher than 78% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$94M in FY2016 to $72M in FY2021.
Based on SEC 10-K filings.
$63M in FY2025 with a 5-year CAGR of +18.6%. Top quartile in the Health Care sector.
Improved from $48M to $63M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +18.6%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 216This company $62.9M Sector average $454.3M
▼
-86.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.6%, indicating consistent growth.
- In FY2025, net income decreased 9.1% year-over-year.
- Ranks #47 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.9M | -9.1% |
| FY2024 | $69.2M | +43.7% |
| FY2023 | $48.2M | +292.6% |
| FY2022 | -$25.0M | -135.0% |
| FY2021 | $71.5M | +167.3% |
| FY2020 | $26.8M | +217.7% |
| FY2019 | -$22.7M | +41.9% |
| FY2018 | -$39.1M | -43.6% |
| FY2017 | -$27.3M | +71.1% |
| FY2016 | -$94.2M | -245.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026